News / Press Releases

A Fresh Look at the Major Cause of Most Myopia

Read about the natural physiological tension that constantly is present in the human eye. This natural tension involves physiology that causes the eye to elongate and physiology that naturally counters this elongation. Learn why the eye becomes myopic despite the fact the eye has natural physiology for preventing such axial elongation.

read more

Announcing Major Advance; Goal to Stop Myopia Progression

NeuroRays has discovered that there is a natural physiological tension that exists in the eye’s retina when ocular light therapy is applied, especially with low level red-light (650nm) therapy (LLRL). By blocking / protecting the macula during ocular light therapy it is possible to not only protect the macula, but remove this natural physiological tension. It is believed that this will not only protect the macula, but further increase the efficacy of LLRL. As you may know, 3rd party research (published in 2025) with LLRL, used in combination with myopia control spectacle lenses, reported 100% efficacy in slowing or stopping myopia progression. Also this year (2025) a newly published 3rd party animal study has shown that by stimulating the peripheral retina, while blocking the macula, an even stronger slowing of myopia occurs. Click on the following link to learn additional details of this significant advance, including adding blue light (480nm) in to the mix.

read more

Safely Stopping Myopia Progression Coming Into Focus

The three recommended steps: Apply Ocular Light Therapy While Protecting the Macula Utilize Myopia Control Lenses in Combination Continue with Myopia Control Lenses To Prevent Rebound The Proof! Low-Level Red-Light Therapy While Protecting the Macula Increases Myopia Control Response2025 | pmc.ncbi.nlm.nih.gov 100% Stoppage of Myopia Progression with Low-Level Red-Light Therapy and Myopia Control Lenses2025 | nature.com2025 | sciencedirect.com The need for Macula Protection with Ocular Light...

read more

NeuroRays™ Announces  Ocular Light Therapy with Macula Protection

There is clear evidence that light impacts our health and well-being. Besides the visual (image-forming) functions of the human ocular system, it is well known that it is also responsible for a number of non-visual functions, such as wake-sleep cycle, mood, alertness, and cognition, among others. [1-6] In fact, using these non-visual functions of the light, ocular photo-biomodulation (ocular PBM or ocular light therapy) has been used for decades to treat certain disorders, such as seasonal...

read more

A Highly Efficient and Sustained Approach for Myopia Control Based on Myopia Control Lenses and Ocular Light Therapy

Figure 1. Schematic presentation of eye anatomy. Myopia, or nearsightedness, is the most common form of refractive abnormality and is characterized by excessive eye elongation, causing distant objects to appear blurry. Elongation of the eye is further enabled by the thinning of the myopic “eye wall” - the choroid and the sclera as presented in Figure 1. Furthermore, with myopia, defocused light (DL) and longitudinal chromatic aberration (LCA) have been implicated as the probable mechanisms...

read more

Controlling Myopia (Nearsightedness) with Targeted Light Wavelengths

(Three Questions, the Answers of Which Could have Profound Implications for the Global Optical Industry) For Release; June 3, 2024, Atlanta, Georgia. NeuroRays, LLC www.NeuroRays.com announced it has invented optogenetic lens designs that use ambient lighting (indoor or outdoor) for the purpose of preventing or controlling Myopia (Nearsightedness).  Optogenetics is a relatively new field of life science that utilizes specific wavelengths of light to stimulate neurons.  The proprietary lens...

read more

NeuroRays™ Hypothesis of the Genesis of Myopia & Myopia Progression

Juvenile-onset myopia (nearsightedness) occurs due to accommodative near point stress that generates a force causing an increase in the axial length of the eye. The resulting axial elongation occurs when the eye’s ocular structure is unable to provide an offsetting force equal to or larger than that of the force causing axial elongation. The weakness of the opposing ocular structural is due to a deficiency of dopamine present in the retina.  Ample retinal dopamine is required to increase...

read more